Retrospective Observational Study of Patients With Subdural Hematoma Treated With Idarucizumab

Use of anticoagulants is increasing with the aging of societies. The safe first-line drug is likely to be a direct oral anticoagulant (DOAC), but outcomes of treatment of traumatic brain injury (TBI) with anticoagulants are uncertain. Therefore, we examined the clinical effect of idarucizumab as rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Suehiro, Eiichi, Ishihara, Hideyuki, Kogeichi, Yohei, Ozawa, Tsunenori, Haraguchi, Koichi, Honda, Masaru, Honda, Yumie, Inaba, Makoto, Kabeya, Ryusuke, Kanda, Naoaki, Koketsu, Kenta, Murakami, Nobukuni, Nakamoto, Hidetoshi, Oshio, Kotaro, Saigusa, Kuniyasu, Shuto, Takashi, Sugiyama, Shuichi, Suzuyama, Kenji, Terashima, Tsuguaki, Tsuura, Mitsuharu, Nakada, Mitsutoshi, Kobata, Hitoshi, Higashi, Toshio, Sakai, Nobuyuki, Suzuki, Michiyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659013/
https://www.ncbi.nlm.nih.gov/pubmed/38028276
http://dx.doi.org/10.1089/neur.2023.0065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659013/
https://www.ncbi.nlm.nih.gov/pubmed/38028276
http://dx.doi.org/10.1089/neur.2023.0065

Ejemplares similares